Stocks
Xylem Financial Statements (XYL) |
||||||||||
| Xylemsmart-lab.ru | % | 2021 | 2022 | 2022 | 2023 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 25.02.2022 | 31.12.2022 | 24.02.2023 | 31.12.2023 | 28.02.2024 | 31.10.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 5 195 | 5 522 | 5 522 | 7 364 | 7 364 | 8 424 | |||
| Operating Income, bln rub | 585.0 | 622.0 | 622.0 | 728.0 | 652.0 | 1 008 | ||||
| EBITDA, bln rub | ? | 853.0 | 601.0 | 755.0 | 1 164 | 1 288 | 1 635 | |||
| Net profit, bln rub | ? | 427.0 | 355.0 | 355.0 | 609.0 | 609.0 | 830.0 | |||
| OCF, bln rub | ? | 538.0 | 596.0 | 596.0 | 837.0 | 837.0 | 1 143 | |||
| CAPEX, bln rub | ? | 208.0 | 208.0 | 208.0 | 271.0 | 271.0 | 315.0 | |||
| FCF, bln rub | ? | 330.0 | 388.0 | 388.0 | 566.0 | 566.0 | 828.0 | |||
| Dividend payout, bln rub | 203.0 | 217.0 | 217.0 | 299.0 | 299.0 | 343.0 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 47.5% | 61.1% | 61.1% | 49.1% | 49.1% | 41.3% | ||||
| OPEX, bln rub | 1 383 | 1 433 | 1 433 | 1 989 | 2 065 | 1 819 | ||||
| Cost of production, bln rub | 3 220 | 3 438 | 3 438 | 4 647 | 4 647 | 5 310 | ||||
| R&D, bln rub | 204.0 | 206.0 | 206.0 | 232.0 | 232.0 | 232.0 | ||||
| Interest expenses, bln rub | 76.0 | 50.0 | 50.0 | 49.0 | 49.0 | 56.0 | ||||
| Assets, bln rub | 8 276 | 7 952 | 7 952 | 16 112 | 16 112 | 16 046 | ||||
| Net Assets, bln rub | ? | 3 218 | 3 494 | 3 494 | 10 166 | 10 166 | 10 593 | |||
| Debt, bln rub | 2 440 | 1 880 | 1 949 | 2 284 | 2 662 | 2 103 | ||||
| Cash, bln rub | 1 349 | 944.0 | 944.0 | 1 019 | 1 019 | 989.0 | ||||
| Net debt, bln rub | 1 091 | 936.0 | 1 005 | 1 265 | 1 643 | 1 114 | ||||
| Ordinary share price, rub | 119.9 | 110.6 | 110.6 | 114.4 | 114.4 | 94.3 | ||||
| Number of ordinary shares, mln | 180.2 | 180.2 | 180.2 | 218.2 | 217.0 | 242.9 | ||||
| Market cap, bln rub | 21 615 | 19 925 | 19 927 | 24 953 | 24 814 | 22 906 | ||||
| EV, bln rub | ? | 22 706 | 20 861 | 20 932 | 26 218 | 26 457 | 24 020 | |||
| Book value, bln rub | -590 | -155 | -155 | 2 579 | 50 | 674 | ||||
| EPS, rub | ? | 2.37 | 1.97 | 1.97 | 2.79 | 2.81 | 3.42 | |||
| FCF/share, rub | 1.83 | 2.15 | 2.15 | 2.59 | 2.61 | 3.41 | ||||
| BV/share, rub | -3.27 | -0.86 | -0.86 | 11.8 | 0.23 | 2.77 | ||||
| EBITDA margin, % | ? | 16.4% | 10.9% | 13.7% | 15.8% | 17.5% | 19.4% | |||
| Net margin, % | ? | 8.22% | 6.43% | 6.43% | 8.27% | 8.27% | 9.85% | |||
| FCF yield, % | ? | 1.53% | 1.95% | 1.95% | 2.27% | 2.28% | 3.61% | |||
| ROE, % | ? | 13.3% | 10.2% | 10.2% | 5.99% | 5.99% | 7.84% | |||
| ROA, % | ? | 5.16% | 4.46% | 4.46% | 3.78% | 3.78% | 5.17% | |||
| P/E | ? | 50.6 | 56.1 | 56.1 | 41.0 | 40.7 | 27.6 | |||
| P/FCF | 65.5 | 51.4 | 51.4 | 44.1 | 43.8 | 27.7 | ||||
| P/S | ? | 4.16 | 3.61 | 3.61 | 3.39 | 3.37 | 2.72 | |||
| P/BV | ? | -36.6 | -128.5 | -128.6 | 9.68 | 496.3 | 34.0 | |||
| EV/EBITDA | ? | 26.6 | 34.7 | 27.7 | 22.5 | 20.5 | 14.7 | |||
| Debt/EBITDA | 1.28 | 1.56 | 1.33 | 1.09 | 1.28 | 0.68 | ||||
| R&D/CAPEX, % | 98.1% | 99.0% | 99.0% | 85.6% | 85.6% | 73.7% | ||||
| CAPEX/Revenue, % | 4.00% | 3.77% | 3.77% | 3.68% | 3.68% | 3.74% | ||||
| Xylem shareholders | ||||||||||
